We are excited to host this year’s first roundtable discussion. For this panel discussion about the COVID-19 pandemic lockdowns, we welcome Professor Linda Bauld (University of Edinburgh), Professor Mark Woolhouse (University of Edinburgh) and Professor Yossi Nehushtan (Keele University).
This talk introduces an embryonic book project that will extend this work in much richer detail. I want to argue, drawing on key case studies across health policy in the UK, that policy actors have good reasons for hanging on to ideals like EBPM, joined-up governance, transparency and citizen engagement in their practice. Namely, I will argue that pursuing these goals helps them a) to cope with the complex demands of contemporary governance, b) to channel their interests and values in persuasive ways, and c) to ensure buy-in from everyone in the face of eliminable complexities and conflicts.
On 10 April 2017, the Scottish Medicines Consortium (SMC) announced that PrEP (pre-exposure prophylaxis) – the use of HIV treatment in people who are HIV-negative to prevent HIV – would soon be available on the NHS. This is a landmark decision for the use of HIV treatment as prevention in the UK, making Scotland the first – and currently, only – country to provide PrEP through the NHS.